Screening & Onboarding
Identification of high-risk patients (e.g., in cases of polypharmacy) and recording of medical history at the Point of Care.
We are pioneers at the intersection of genomics and clinical practice. By combining state-of-the-art DNA sequencing with highly sophisticated pharmacological intelligence, YAI-Clinic is leading healthcare far beyond the era of standard medication. In close collaboration with global innovation leaders, we translate complex genetic data into precise, risk-minimized therapy decisions – for medicine that is as unique as the human being itself.
Improving individual health through personalized therapy recommendations (medication, lifestyle, nutrition) based on comprehensive diagnoses and tests.
The partnership between diagnostic companies and the YAI-Clinic builds a bridge from pure data collection to clinical application.
A cooperation with the YAI-Clinic enables diagnostic companies to enter the diagnostics market through the use of advanced bioinformatics and pharmacogenomics.
The partnership between diagnostic companies and the YAI-Clinic creates a bridge from pure data collection to clinical application.
Identification of high-risk patients (e.g., in cases of polypharmacy) and recording of medical history at the Point of Care.
Execution of genetic, epigenetic, and metabolic tests (e.g., Metabolic Panel) in cooperation with partners.
Linking laboratory data with insurance data (payer data) and real-world evidence (RWE) for a holistic assessment.
Final assessment by clinical pharmacologists and nutrition specialists for risk mitigation.